Journal of perinatology : official journal of the California Perinatal Association · 2019
Decrease in the frequency of treatment for patent ductus arteriosus after implementation of consensus guidelines: a 15-year experience.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pavageau Lara, Brion Luc P, Rosenfeld Charles R, Brown L Steven, Ramaciotti Claudio, Burchfield P Jeannette, Jaleel Mambarambath A
Аннотация
BACKGROUND: Patent ductus arteriosus (PDA) management varies widely among neonatologists.
LOCAL PROBLEM: Lack of institution-specific evidence-based guidelines for therapeutic closure of PDA.
METHODS: Quality improvement project among infants <30 weeks gestational age (GA) designed to determine whether the odds of therapy for closing the PDA, adjusted for GA, decreased after implementing evidence-based guidelines.
INTERVENTION: Implementation of guidelines with conservative approach to PDA management.
RESULTS: The frequency of PDA treatment decreased from 446/1125 (40%) in Epoch 1 to 96/482 (20%) in Epoch 2. PDA treatment was more frequent in neonates 23-26 weeks GA than those of 27-29 weeks GA (43% vs. 28%, respectively). Among 542 infants receiving indomethacin for PDA, 25% had subsequent ligation; the odds of ligation after indomethacin were lower in neonates 27-29 weeks GA and decreased during Epoch 2.
CONCLUSIONS: The frequency of medical and surgical treatment for therapeutic closure of PDA decreased after implementing evidence-based treatment guidelines.
LOCAL PROBLEM: Lack of institution-specific evidence-based guidelines for therapeutic closure of PDA.
METHODS: Quality improvement project among infants <30 weeks gestational age (GA) designed to determine whether the odds of therapy for closing the PDA, adjusted for GA, decreased after implementing evidence-based guidelines.
INTERVENTION: Implementation of guidelines with conservative approach to PDA management.
RESULTS: The frequency of PDA treatment decreased from 446/1125 (40%) in Epoch 1 to 96/482 (20%) in Epoch 2. PDA treatment was more frequent in neonates 23-26 weeks GA than those of 27-29 weeks GA (43% vs. 28%, respectively). Among 542 infants receiving indomethacin for PDA, 25% had subsequent ligation; the odds of ligation after indomethacin were lower in neonates 27-29 weeks GA and decreased during Epoch 2.
CONCLUSIONS: The frequency of medical and surgical treatment for therapeutic closure of PDA decreased after implementing evidence-based treatment guidelines.
Предметные рубрики MeSH
Cardiac Surgical ProceduresConsensusCyclooxygenase InhibitorsDisease ManagementDuctus Arteriosus, PatentFemaleGestational AgeGuideline AdherenceHumansIndomethacinInfant, NewbornInfant, PrematureIntensive Care Units, NeonatalLigationLogistic ModelsMaleQuality ImprovementTexasTime-to-TreatmentTreatment Failure